Clinical Trial Update: Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effect of glucose degradation products on endothelial dysfunction in patients with chronic kidney disease undergoing peri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Peritoneal Dialysis-related Disorders

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Kidney Failure, Chronic, Disorders Associated With Peritoneal Dialysis | Phase 4 | Status: COMPLETED